Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Healthcare Company (ACHC) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for Acadia Healthcare Company (ACHC) over the last 16 years, with Q3 2025 value amounting to $118.7 million.

  • Acadia Healthcare Company's Cash & Current Investments rose 4449.21% to $118.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $118.7 million, marking a year-over-year increase of 4449.21%. This contributed to the annual value of $76.3 million for FY2024, which is 2375.07% down from last year.
  • As of Q3 2025, Acadia Healthcare Company's Cash & Current Investments stood at $118.7 million, which was up 4449.21% from $131.4 million recorded in Q2 2025.
  • Acadia Healthcare Company's 5-year Cash & Current Investments high stood at $196.3 million for Q3 2021, and its period low was $63.8 million during Q1 2023.
  • Its 5-year average for Cash & Current Investments is $115.0 million, with a median of $100.1 million in 2023.
  • Data for Acadia Healthcare Company's Cash & Current Investments shows a peak YoY increase of 12087.18% (in 2021) and a maximum YoY decrease of 6466.49% (in 2021) over the last 5 years.
  • Quarter analysis of 5 years shows Acadia Healthcare Company's Cash & Current Investments stood at $133.8 million in 2021, then decreased by 27.03% to $97.6 million in 2022, then grew by 2.48% to $100.1 million in 2023, then dropped by 23.75% to $76.3 million in 2024, then skyrocketed by 55.55% to $118.7 million in 2025.
  • Its last three reported values are $118.7 million in Q3 2025, $131.4 million for Q2 2025, and $91.2 million during Q1 2025.